Cancer

New research has uncovered a mechanism thought to explain why some cancers don't respond to a widely used form of immunotherapy called “checkpoint inhibitors” or anti-PD-1.

Fung-Lung Chung can't wait to find out if his mother's belief in the health-promoting properties of the hot green tea she served after meals will be scientifically validated by a…

Every three months, Dr. Christina Hanna (F'08, M'14) packs her bags and travels from Philadelphia to Butaro, Rwanda, where she treats young cancer patients.

The immunotherapy that is revolutionizing treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center.

Lucile Adams-Campbell, professor of oncology and senior associate dean for community outreach and engagement, was named a 2018 Washingtonian of the Year.

Washingtonian magazine named Lucile Adams-Campbell a Washingtonian of the Year. She's a national leader in minority health and health disparities research.

A study of obese mice by a Georgetown Lombardi Comprehensive Cancer Center research team has found a natural protein to be a powerful regulator in metabolism.

Researchers at Georgetown University Medical Center have found distinct molecular signatures in two brain disorders long thought to be psychological in origin—chronic fatigue syndrome and Gulf War Illness.

Georgetown researchers have developed a new diagnostic tool for bladder cancer that may reduce unnecessary treatment for patients with non-invasive tumors.

David Habin Song, MD, MBA, is on a mission to make Georgetown University School of Medicine and MedStar Health the best academic health system in the country for plastic surgery.